AONN-NSC 2018 - 9th Annual AONN Navigation & Survivorship Conference

Nov 15 - Nov 18, 2018 | DallasTXUS

LARVOL is not affiliated with 9th Annual AONN Navigation & Survivorship Conference and all trademarks, logos, and brand names are property of their respective owners

Showing 11 abstracts linked to Trials

Using Technology in Practice to Improve Patient Symptoms: the eCO experience

Adverse event management during treatment with alpelisib for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer

Efficacy, Safety, and Quality of Life in Premenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Treated With Ribociclib Combination Therapy: A Review of the Phase 3 MONALEESA-7 Trial

Health status in patients with small-cell lung cancer treated with nivolumab alone or combined with ipilimumab: CheckMate 032